Amgen (AMGN) Revenue (2009 - 2026)
Amgen's quarterly Revenue came in at $8.6 billion in Q1 2026, up 5.76% year-on-year from $8.1 billion in Q1 2025, and down 12.65% quarter-over-quarter from $9.9 billion in Q4 2025.
Amgen has reported Revenue for 18 years, with the latest figure at $8.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 5.76% year-over-year to $8.6 billion; the trailing twelve-month figure through Mar 2026 stood at $37.2 billion (up 9.07% YoY), and the FY2025 full-year result was $36.8 billion, up 9.95% from the prior year.
- Revenue for Q1 2026 stood at $8.6 billion, down from $9.9 billion in the prior quarter.
- The five-year high for Revenue was $9.9 billion in Q4 2025, with the low at $459.0 million in Q4 2022.
- Average Revenue over 5 years is $7.5 billion, with a median of $8.1 billion recorded in 2025.
- Year-over-year, Revenue sank 93.3% in 2022 and jumped 1685.62% in 2023.
- Tracing AMGN's Revenue over 5 years: stood at $459.0 million in 2022, then jumped by 1685.62% to $8.2 billion in 2023, then grew by 10.86% to $9.1 billion in 2024, then grew by 8.58% to $9.9 billion in 2025, then declined by 12.65% to $8.6 billion in 2026.
- The last three Revenue figures came in at $8.6 billion (Q1 2026), $9.9 billion (Q4 2025), and $9.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 19.80 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 24.06 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 15.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 11.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.62 Bn |
| Dec 31, 2025 | 9.87 Bn |
| Sep 30, 2025 | 9.56 Bn |
| Jun 30, 2025 | 9.18 Bn |
| Mar 31, 2025 | 8.15 Bn |
| Dec 31, 2024 | 9.09 Bn |
| Sep 30, 2024 | 8.50 Bn |
| Jun 30, 2024 | 8.39 Bn |
| Mar 31, 2024 | 7.45 Bn |
| Dec 31, 2023 | 8.20 Bn |
| Sep 30, 2023 | 6.90 Bn |
| Jun 30, 2023 | 6.99 Bn |
| Mar 31, 2023 | 6.11 Bn |
| Dec 31, 2022 | 459.00 Mn |
| Sep 30, 2022 | 6.65 Bn |
| Jun 30, 2022 | 6.59 Bn |
| Mar 31, 2022 | 6.24 Bn |
| Dec 31, 2021 | 6.85 Bn |
| Sep 30, 2021 | 6.71 Bn |
| Jun 30, 2021 | 6.53 Bn |
| Mar 31, 2021 | 5.90 Bn |
| Dec 31, 2020 | 6.33 Bn |
| Sep 30, 2020 | 6.42 Bn |
| Jun 30, 2020 | 6.21 Bn |
| Mar 31, 2020 | 6.16 Bn |
| Dec 31, 2019 | 5.88 Bn |
| Sep 30, 2019 | 5.46 Bn |
| Jun 30, 2019 | 5.57 Bn |
| Mar 31, 2019 | 5.29 Bn |
| Dec 31, 2018 | 6.00 Bn |
| Sep 30, 2018 | 5.51 Bn |
| Jun 30, 2018 | 5.68 Bn |
| Mar 31, 2018 | 5.34 Bn |
| Dec 31, 2017 | 5.57 Bn |
| Sep 30, 2017 | 5.45 Bn |
| Jun 30, 2017 | 5.57 Bn |
| Mar 31, 2017 | 5.20 Bn |
| Dec 31, 2016 | 5.66 Bn |
| Sep 30, 2016 | 5.52 Bn |
| Jun 30, 2016 | 5.47 Bn |
| Mar 31, 2016 | 5.24 Bn |
| Dec 31, 2015 | 5.33 Bn |
| Sep 30, 2015 | 5.52 Bn |
| Jun 30, 2015 | 5.23 Bn |
| Mar 31, 2015 | 4.87 Bn |
| Dec 31, 2014 | 5.17 Bn |
| Sep 30, 2014 | 4.85 Bn |
| Jun 30, 2014 | 4.95 Bn |
| Mar 31, 2014 | 4.36 Bn |
| Dec 31, 2013 | 4.80 Bn |
| Sep 30, 2013 | 4.65 Bn |
| Jun 30, 2013 | 4.60 Bn |
| Mar 31, 2013 | 4.15 Bn |
| Dec 31, 2012 | 4.34 Bn |
| Sep 30, 2012 | 4.20 Bn |
| Jun 30, 2012 | 4.20 Bn |
| Mar 31, 2012 | 3.90 Bn |
| Dec 31, 2011 | 3.91 Bn |
| Sep 30, 2011 | 3.88 Bn |
| Jun 30, 2011 | 3.89 Bn |
| Mar 31, 2011 | 3.62 Bn |
| Dec 31, 2010 | 3.76 Bn |
| Sep 30, 2010 | 3.76 Bn |
| Jun 30, 2010 | 3.61 Bn |
| Mar 31, 2010 | 3.53 Bn |
| Dec 31, 2009 | 3.74 Bn |
| Sep 30, 2009 | 3.74 Bn |
| Jun 30, 2009 | 3.63 Bn |
| Mar 31, 2009 | 3.24 Bn |